Roundup and Breast Cancer
From: Riggs Eckelberry
Los Angeles, August 21, 2017
You know it as Monsanto’s Roundup. And it correlates closely with the explosion in breast and prostate cancers, among others.
Here is just one of many stunning graphs.
What’s glyphosate? It’s is the active ingredient in Roundup.
Monsanto’s patent expired in 2000, and now the whole world makes it.
It is the world’s most popular herbicide (weed-killer).
At one time, it was considered quite safe.
But, a growing body of research ties Roundup (glyphosate) to breast and other cancers, including prostate:
- Glyphosate induces human breast cancer cells growth via estrogen receptors.
- Glyphosate-based herbicides are toxic and endocrine disruptors in human cell lines.
- Glyphosate, pathways to modern diseases IV: cancer and related pathologies.
This new research is still highly controversial and we do not endorse it; but prudence would dictate getting the Roundup (glyphosate) out.
It’s not going to go away; best to remove it from our drinking water.
What can we do about it?
People are spending thousands of dollars on expensive filtration systems that may get it all out. But not everyone has that kind of money.
Our technology is different. We use electricity. It is highly efficient.
For this and many other contaminants in our fresh water, we believe that ours is the technology of the future.
An ambitious program
We have launched a far-reaching program to complete the testing, finalize the process, and get it into the market through partners.
A very exciting part of the program may include sophisticated gene testing on lab animals.
Have a great week!
Riggs and Team
President & CEO
OriginClear, Inc. (OCLN)
* This communication shall not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such solicitation or sale would be unlawful prior to registration or qualification of these securities under the laws of any such state.
Safe Harbor Statement:
Matters discussed in this release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein, and while expected, there is no guarantee that we will attain the aforementioned anticipated developmental milestones. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.